[LCID Study Number: 20203173]

Utilization of dd-cfDNA in Treatment and Monitoring of Renal Transplant Patients with BKPyV DNAemia and BKPyV Associated Nephropathy

The purpose of this study is to evaluate the usefulness of the AlloSure NGS platform in measuring dd-cfDNA for treatment and monitoring of renal transplant patients with BKPyV DNAemia and BKPyV associated nephropathy.

Disease/Condition: Kidney Transplant

Department: Transplantation & Hepatobiliary Diseases

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: [email protected]